Nos articles
  • 2019-2022
  • 2013-2018
  • 2007-2012
  • 2000-2006
Transcriptomic modulation in response to high-intensity interval training in monocytes of older women with type 2 diabetes via Eur J Appl Physiol (2022), Vol. 122, No. 4, PP. 1085-95
by Hamelin Morrissette J, Tremblay D, Marcotte-Chénard A, Lizotte F, Brunet MA, Laurent B, Riesco E, Geraldes P.
Université de Sherbrooke
DOI: 10.1007/s00421-022-04911-9
Diabetes Impaired Ischemia-Induced PDGF (Platelet-Derived Growth Factor) Signaling Actions and Vessel Formation Through the Activation of Scr Homology 2-Containing Phosphatase-1 via ATVB (2021), Vol. 41, No. 9, PP. 2469-82
by Mercier C, Brazeau T, Lamoureux J, Boisvert E, Robillard S, Breton V, Paré M, Guay A, Lizotte F, Despatis MA, Geraldes P.
Université de Sherbrooke
DOI: 10.1161/ATVBAHA.121.316638
Fish oil replacement prevents, while docosahexaenoic acid-derived protectin DX mitigates end-stage-renal-disease in atherosclerotic diabetic mice via FASEB Journal (2021), Vol. 35, No. 5, PP. e21559
by Perazza LR, Mitchell PL, Lizotte F, Jensen BAH, St-Pierre P, Trottier J, Barbier O, Mathieu P, Geraldes PM, Marette A.
Université Laval et Sherbrooke
DOI: 10.1096/fj.202100073R
Endothelial deletion of PKCδ prevents VEGF inhibition and restores blood flow reperfusion in diabetic ischemic limb via Diabetes and Vascular Disease Research (2021), Vol. 18, No. 2, PP. 1479164121999033
by Croteau L, Mercier C, Fafard-Couture É, Nadeau A, Robillard S, Breton V, Guay A, Lizotte F, Despatis MA, Geraldes P.
Université de Sherbrooke
DOI: 10.1177/1479164121999033
Growth Factor Deregulation and Emerging Role of Phosphatases in Diabetic Peripheral Artery Disease via Frontier Cardiovascular Medicine (2021), Vol. 7, No. , PP. 619612
by Mercier C, Rousseau M, Geraldes P.
Université de Sherbrooke
DOI: 10.3389/fcvm.2020.619612
Saturated fatty acids induce insulin resistance in podocytes through inhibition of IRS1 via activation of both IKKβ and mTORC1 via Scientific Reports (2020), Vol. 10, No. 1, PP. 21628
by Denhez B, Rousseau M, Spino C, Dancosst DA, Dumas MÈ, Guay A, Lizotte F, Geraldes P.
Université de Sherbrooke
DOI: 10.1038/s41598-020-78376-1
Ablation of angiotensin type 2 receptor prevents endothelial nitric oxide synthase glutathionylation and nitration in ischaemic abductor muscle of diabetic mice via Diabetes and Vascular Disease Research (2020), Vol. 17, No. 1, PP. 1479164119883978
by Robillard S, Mercier C, Breton V, Paquin-Veillette J, Guay A, Lizotte F, Geraldes P.
Université de Sherbrooke
DOI: 10.1177/1479164119883978
Calcifediol Decreases Interleukin-6 Secretion by Cultured Human Trophoblasts From GDM Pregnancies via J Endocr Soc (2019), Vol. 3, No. 11, PP. 2165-2178
by Lacroix M, Lizotte F, Hivert M-F, Geraldes P, Perron P.
Université de Sherbrooke
DOI: 10.1210/js.2019-00181
Mice lacking angiotensin type 2 receptor exhibit a sex-specific attenuation of insulin sensitivity via Mol Cell Endocrinol (2019), Vol. 498, PP. 110587
by Quiroga DT, Miquet JG, Gonzalez L, Sotelo AI, Muñoz MC, Geraldes P, Giani JF, Dominici FB
Universidad de Buenos Aires and Université de Sherbrooke
DOI: 10.1016/j.mce.2019.110587
Diabetes-induced DUSP4 reduction promotes podocyte dysfunction and progression of diabetic nephropathy via Diabetes (2019), Vol. 68, No. 5, PP. 1026-39
by Denhez B, Rousseau M, Dancosst DA, Lizotte F, Guay A, Auger-Messier M, Côté AM, Geraldes P.
Université de Sherbrooke
DOI: 10.2337/db18-08378
Combination of high-fat/high-fructose diet and low-dose streptozotocin to model long-term type-2 diabetes complications via Sci Rep (2018), Vol. 8, No. 1, PP. 424
by Barrière DA, Noll C, Roussy G, Lizotte F, Kessai A, Kirby K, Belleville K, Beaudet N, Longpré JM, Carpentier AC, Geraldes P, Sarret P.
Université de Sherbrooke
DOI: 10.1038/s41598-017-18896-5
Protein phosphatases and podocyte function via Curr Opin Nephrol Hypertens (2018), Vol. 27, No. 1, PP. 49-55
by Geraldes P.
Université de Sherbrooke
DOI: 10.1097/MNH.0000000000000376
Deletion of AT2 Receptor Prevents SHP-1-Induced VEGF Inhibition and Improves Blood Flow Reperfusion in Diabetic Ischemic Hindlimb via ATVB (2017), Vol. 37, No. 12, PP. 2291-2300
by Paquin-Veillette J, Lizotte F, Robillard S, Béland R, Breton MA, Guay A, Despatis MA, Geraldes P.
Université de Sherbrooke
DOI: 10.1161/ATVBAHA.117.309977
Regulation of Nephrin Phosphorylation in Diabetes and Chronic Kidney Injury via Adv Exp Med Biol (2017), Vol. 966, PP. 149-161
by Denhez B, Geraldes P.
Université de Sherbrooke
DOI: 10.1007/5584_2017_62
Persistent insulin resistance in podocytes caused by epigenetic changes of SHP-1 in diabetes via Diabetes (2016), Vol. 65, No. 12, PP. 3705-3717
by Lizotte F, Denhez B, Guay A, Gévry N, Côté AM, Geraldes P.
Université de Sherbrooke
DOI: 10.2337/db16-0254
PKC beta activation inhibits interleukin-18 binding protein causing endothelial dysfunction and accelerated diabetic atherosclerosis via Cardiovasc Res. (2015), Vol. 106, No. 2, PP. 303-313
by Durpès MC, Morin C, Paquin-Veillet J, Beland R, Paré M, Guimond MO, Rekhter M, King GL, Geraldes P.
Université de Sherbrooke
DOI: 10.1093/cvr/cvv107
Increased SHP-1 expression by high glucose levels reduced nephrin phosphorylation in podocytes via JBC (2015), Vol. 290, No. 1, PP. 350-358
by Denhez B, Lizotte F, Guimond MO, Jones N, Takano T, Geraldes P.
Université de Sherbrooke
DOI: 10.1074/jbc.M114.612721
PKCδ impaired vessel formation and angiogenic factor expression in diabetic ischemic limbs via Diabetes (2013), Vol. 62, No. 8, PP. 2948-2957
by Lizotte F, Paré M, Denhez B, Leitges M, Guay A, Geraldes P.
Université de Sherbrooke
DOI: 10.2337/db12-1432
Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes via Am J Physiol Endocrinol Metab (2013), Vol. 304, No. 11, PP. E1188-98
by Drapeau N, Lizotte F, Denhez B, Guay A, Kennedy CR, Geraldes P.
Université de Sherbrooke
DOI: 10.1152/ajpendo.00560.2012
Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetes via Diabete (2012), Vol. 61, No. 11, PP. 2967-2979
by Mima A, Hiraoka-Yamomoto J, Li Q, Kitada M, Li C, Geraldes P, Matsumoto M, Mizutani K, Park K, Cahill C, Nishikawa S, Rask-Madsen C, King GL.
Joslin Diabetes Center, Harvard University, Boston
DOI: 10.2337/db11-1824
Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy via FASEBJ (2012), Vol. 27, No. 6, PP. 2963-2974
by Mima A, Kitada M, Geraldes P, Li Q, Matsumoto M, Mizutani K, Qi W, Li C, Leitges M, Rask-Madsen C, King GL.
Joslin Diabetes Center, Harvard University, Boston
DOI: 10.1096/fj.11-202994
Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity via Kidney Int (2011), Vol. 79, No. 8, PP. 883-896
by Mima A, Ohshiro Y, Kitada M, Matsumoto M, Geraldes P, Li C, Li Q, White GS, Cahill C, Rask-Madsen C, King GL.
Joslin Diabetes Center, Harvard University, Boston
DOI: 10.1038/ki.2010.526
Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice via Cell Metabol (2010), Vol. 11, No. 5, PP. 379-389
by Rask-Madsen C, Li Q, Freund B, Feather D, Abramov R, Wu IH, Chen K, Yamamoto-Hiraoka J, Goldenbogen J, Sotiropoulos KB, Clermont A, Geraldes P, Dall'Osso C, Wagers AJ, Huang PL, Rekhter M, Scalia R, Kahn CR, King GL.
Joslin Diabetes Center, Harvard University, Boston
DOI: 10.1016/j.cmet.2010.03.013
Activation of protein kinase C isoforms and its impact on diabetic complications via Circ Res (2010), Vol. 106, No. 8, PP. 1319-1331
by Geraldes P, King GL.
Joslin Diabetes Center, Harvard University, Boston
DOI: 10.1161/CIRCRESAHA.110.217117
Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy via Nat Med (2009), Vol. 15, No. 11, PP. 1298-1306
by Geraldes P, Hiraoka-Yamamoto J, Matsumoto M, Clermont A, Leitges M, Marette A, Aiello LP, Kern TS, King GL.
Joslin Diabetes Center, Harvard University, Boston
DOI: 10.1038/nm.2052
p38 MAPK is a major regulator of MafA protein stability under oxidative stress via Mol Endocrinol (2009), Vol. 23, No. 8, PP. 1281-1290
by Kondo T, El Khattabi I, Nishimura W, Laybutt DR, Geraldes P, Shah S, King G, Bonner-Weir S, Weir G, Sharma A.
Joslin Diabetes Center, Harvard University, Boston
DOI: 10.1210/me.2008-0482
Selective regulation of heme oxygenase-1 expression and function by insulin through IRS1/phosphoinositide 3-kinase/Akt-2 pathway via J Biol Chem (2008), Vol. 283, No. 49, PP. 34327-36
by Geraldes P, Yagi K, Ohshiro Y, He Z, Maeno Y, Yamamoto-Hiraoka J, Rask-Madsen C, Chung SW, Perrella MA, King GL.
Joslin Diabetes Center, Harvard University, Boston
DOI: 10.1074/jbc.M807036200
Local delivery of 17-beta-estradiol modulates collagen content in coronary porcine arteries after PTCA and stent implantation via J Vasc Res (2008), Vol. 45, No. 6, PP. 503-11
by Geraldes P, Geoffroy P, Cloutier I, Sirois MG, Tanguay JF.
Montreal Heart Institute, Université de Montréal, Montréal
DOI: 10.1159/000128603
Glypican 4, a membrane binding protein for bactericidal/permeability-increasing protein signaling pathways in retinal pigment epithelial cells via Invest Ophthalmol Vis Sci (2007), Vol. 48, No. 12, PP. 5750-5
by Geraldes P, Yamagata M, Rook SL, Sassa Y, Ma RC, Clermont A, Gao B, Aiello LP, Feener EP, King GL.
Joslin Diabetes Center, Harvard University, Boston
DOI: 10.1167/iovs.07-0470
Tamoxifen treatment of myocardial infarcted female rats exacerbates scar formation via J Vasc Res (2008), Vol. 454, No. 3, PP. 385-93
by Geraldes P, Gosselin H, Tanguay JF, Clément R, Calderone A.
Montreal Heart Institute, Université de Montréal, Montréal
DOI: 10.1007/s00424-007-0215-5
Bactericidal/permeability-increasing protein's signaling pathways and its retinal trophic and anti-angiogenic effects via FASEBJ (2006), Vol. 20, No. 12, PP. 2058-67
by Yamagata M, Rook SL, Sassa Y, Ma RC, Geraldes P, Goddard L, Clermont A, Gao B, Salti H, Gundel R, White M, Feener EP, Aiello LP, King GL.
Joslin Diabetes Center, Harvard University, Boston
DOI: 10.1096/05-5662com
Estradiol blocks the induction of CD40 and CD40L expression on endothelial cells and prevents neutrophil adhesion: an ERalpha-mediated pathway via Cardiovasc Res (2006), Vol. 454, No. 3, PP. 385-93
by Geraldes P, Gagnon S, Hadjadj S, Merhi Y, Sirois MG, Cloutier I, Tanguay JF.
Montreal Heart Institute, Université de Montréal, Montréal
DOI: 10.1016/j.cardiores.2006.05.015
Diverse effects of Ace inhibitors and angiotensin II receptor antagonists on prevention of cardiac hypertrophy and collagen distribution in spontaneously hypertensive rats via Int J Cardiol (2004), Vol. 97, No. 3, PP. 373-81
by Gagnon C, Legault F, Geraldes P, Tanguay JF, Lambert C.
Université de Montréal, Montréal
DOI: 10.1016/j.ijcard.2003.10.016
Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation via Circ Res (2003), Vol. 93, No. 5, PP. 399-405
by Geraldes P, Sirois MG, Tanguay JF.
Montreal Heart Institute, Université de Montréal, Montréal
DOI: 10.1161/01.RES.0000088640.18462.42
Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: role of p38 and p42/44 mitogen-activated protein kinase via ATVB (2002), Vol. 22, No. 10, PP. 1585-90
by Geraldes P, Sirois MG, Bernatchez PN, Tanguay JF.
Montreal Heart Institute, Université de Montréal, Montréal
PMID: 12377734